Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Columns with all "N/A" values were excluded
While the level of evidence for each compound varies, all of them lack the kind of large, well-controlled trials in humans that are necessary to establish safety and effectiveness, which is required for drug approvals
Studies have shown BPC-157 can reduce intestinal ulcers in models of inflammatory bowel disease - both ulcerative colitis and Crohn's disease
There is also the question of immunogenicity, which refers to the ability of a substance to provoke an immune response
US$ 22.95
US$ 20.16
US$ 25.66
